antihypertensives_upd

Upload: lady-mae-ramos

Post on 10-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 Antihypertensives_upd

    1/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Drugs AffectingDrugs AffectingBlood PressureBlood Pressure

  • 8/8/2019 Antihypertensives_upd

    2/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Blood Pressure ControlBlood Pressure ControlElementsElements

    Heart RateHeart Rate

    Stroke VolumeStroke Volume

    Peripheral Vascular Peripheral Vascular ResistanceResistance

  • 8/8/2019 Antihypertensives_upd

    3/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Blood Pressure ControlBlood Pressure ControlBaroreceptorsBaroreceptors

    ReninRenin--Angiotensin System Angiotensin System

  • 8/8/2019 Antihypertensives_upd

    4/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    HypertensionHypertensionHigh blood pressureHigh blood pressure

    Normal:Normal: Systolic < 130 mmHgSystolic < 130 mmHg

    Diastolic < 85 mm HgDiastolic < 85 mm Hg

  • 8/8/2019 Antihypertensives_upd

    5/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Classification of Blood PressureClassification of Blood Pressure

    CategoryCategory Systemic BP (mm Hg)Systemic BP (mm Hg) Diastolic BP (mm Hg)Diastolic BP (mm Hg)

    NormalNormal

  • 8/8/2019 Antihypertensives_upd

    6/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Classification of Blood PressureClassification of Blood Pressure

    Primary HypertensionPrimary Hypertension

    Specific cause unknownSpecific cause unknown

    90% of the cases90% of the casesAlso known as essential or idiopathic hypertension Also known as essential or idiopathic hypertension

    Secondary HypertensionSecondary Hypertension

    Cause is known (such as eclampsia of pregnancy,Cause is known (such as eclampsia of pregnancy,renal artery disease, pheochromocytoma)renal artery disease, pheochromocytoma)

    10% of the cases10% of the cases

  • 8/8/2019 Antihypertensives_upd

    7/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 1: Lifestyle modificationStep 1: Lifestyle modification

    weight reductionweight reduction

    reductionreductionmoderation of alcohol intakemoderation of alcohol intake

    smoking cessationsmoking cessation

    physical activity increasephysical activity increase

  • 8/8/2019 Antihypertensives_upd

    8/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 2 : Inadequate ResponseStep 2 : Inadequate Response

    continue lifestyle modificationcontinue lifestyle modification

    initial drug selectioninitial drug selection

    1. Diuretic or Beta blocker 1. Diuretic or Beta blocker

    2. ACE inhibitor, calcium channel2. ACE inhibitor, calcium channelblocker, ARBblocker, ARB

  • 8/8/2019 Antihypertensives_upd

    9/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 3 : Inadequate ResponseStep 3 : Inadequate Response

    increase drug dose, or increase drug dose, or

    substitute another drug, or substitute another drug, or

    add a 2add a 2 ndnd drug from another classdrug from another class

  • 8/8/2019 Antihypertensives_upd

    10/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 4 : Inadequate ResponseStep 4 : Inadequate Response

    add a 2add a 2 ndnd or 3or 3 rdrd agent or diuretic if notagent or diuretic if notalready prescribedalready prescribed

  • 8/8/2019 Antihypertensives_upd

    11/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    HypotensionHypotension

    Hypotensive states:Hypotensive states:

    Heart muscle is damagedHeart muscle is damaged

  • 8/8/2019 Antihypertensives_upd

    12/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Blood Pressure = COBlood Pressure = CO x x SVRSVR

    CO = Cardiac outputCO = Cardiac output

    SVR = Systemic vascular resistanceSVR = Systemic vascular resistance

  • 8/8/2019 Antihypertensives_upd

    13/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Instructors may want to insertInstructors may want to insertEIC Image #69:EIC Image #69:

    Blood Pressure: Normal RegulationBlood Pressure: Normal Regulation

  • 8/8/2019 Antihypertensives_upd

    14/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents Antihypertensive Agents

    Medications used to treat hypertensionMedications used to treat hypertension

  • 8/8/2019 Antihypertensives_upd

    15/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Ag ents:Antihypertensive Ag ents:

    Cate g oriesCate g oriesSympathetic Nervous SystemSympathetic Nervous SystemBlockers/Adrenergic agentsBlockers/Adrenergic agents

    Angiotensin Angiotensin- -converting enzyme inhibitorsconverting enzyme inhibitorsAngiotensin II receptor blockers Angiotensin II receptor blockers

    Calcium channel blockersCalcium channel blockers

    DiureticsDiuretics

    VasodilatorsVasodilators

  • 8/8/2019 Antihypertensives_upd

    16/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Categories Antihypertensive Agents: Categories

    Sympathetic Nervous System Blockers/ Adrenergic agents

    Alpha1 blockers Alpha1 blockers

    Beta blockers (cardioselective and nonselective)Beta blockers (cardioselective and nonselective)

    Centrally acting alpha blockersCentrally acting alpha blockers

    Combined alphaCombined alpha- -beta blockersbeta blockers

    PeripheralPeripheral- -acting adrenergic agentsacting adrenergic agents

  • 8/8/2019 Antihypertensives_upd

    17/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Mechanism of ActionMechanism of ActionAdrener g ic Ag entsAdrener g ic Ag ents

    Alpha1 Blockers Alpha1 Blockers (peripherally acting)(peripherally acting)Block the alpha1Block the alpha1- -adrenergic receptorsadrenergic receptorsThe SNS is not stimulatedThe SNS is not stimulated

    Result: DECREASED blood pressureResult: DECREASED blood pressure

    Stimulation of alpha1Stimulation of alpha1- -adrenergic receptorsadrenergic receptorscauses HYPERtensioncauses HYPERtensionBlocking alpha1Blocking alpha1- -adrenergic receptors causes decreasedadrenergic receptors causes decreasedblood pressureblood pressure

  • 8/8/2019 Antihypertensives_upd

    18/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Adrenergic Agents Adrenergic Agents

    Alpha1 Blockers Alpha1 Blockers

    doxazosin (Cardura)doxazosin (Cardura)

    prazosin (Minipress)prazosin (Minipress)

    terazosin (Hytrin)terazosin (Hytrin)

  • 8/8/2019 Antihypertensives_upd

    19/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Mechanism of ActionMechanism of Action Adrenergic Agents Adrenergic Agents

    CentralCentral- -Acting Adrenergics Acting Adrenergics

    Stimulate alpha2Stimulate alpha2- -adrenergic receptorsadrenergic receptors

    Sympathetic outflow from the CNS is decreasedSympathetic outflow from the CNS is decreased

    Result: decreased blood pressureResult: decreased blood pressure

  • 8/8/2019 Antihypertensives_upd

    20/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Adrenergic Agents Adrenergic Agents

    CentralCentral- -Acting Adrenergics Acting Adrenergics

    clonidine (Catapres)clonidine (Catapres)

    methyldopa (Aldomet)methyldopa (Aldomet)(drug of choice for hypertension in pregnancy)(drug of choice for hypertension in pregnancy)

  • 8/8/2019 Antihypertensives_upd

    21/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Mechanism of ActionMechanism of Action Adrenergic Agents Adrenergic Agents

    Adrenergic Neuronal Blockers Adrenergic Neuronal Blockers(peripherally acting)(peripherally acting)

    Inhibit release of norepinephrineInhibit release of norepinephrine

    Also deplete norepinephrine stores Also deplete norepinephrine stores

    SNS (peripheral adrenergic nerves) is not stimulatedSNS (peripheral adrenergic nerves) is not stimulated

    Result: decreased blood pressureResult: decreased blood pressure

  • 8/8/2019 Antihypertensives_upd

    22/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Adrenergic Agents Adrenergic Agents

    Adrenergic Neuronal Blockers Adrenergic Neuronal Blockers(peripherally acting)(peripherally acting)

    reserpinereserpine

    guanadrel (Hylorel)guanadrel (Hylorel)

    guanethidine (Ismelin)guanethidine (Ismelin)

  • 8/8/2019 Antihypertensives_upd

    23/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents: Adrenergic Agents Adrenergic AgentsTherapeutic UsesTherapeutic Uses

    Alpha1 blockers (peripherally acting) Alpha1 blockers (peripherally acting)

    Treatment of hypertensionTreatment of hypertension

    Relief of symptoms of BPHRelief of symptoms of BPH

    Management of of severe CHF when usedManagement of of severe CHF when usedwith cardiac glycosides and diureticswith cardiac glycosides and diuretics

  • 8/8/2019 Antihypertensives_upd

    24/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Adrenergic Agents Adrenergic AgentsTherapeutic UsesTherapeutic Uses

    CentralCentral- -Acting Adrenergics Acting Adrenergics

    Treatment of hypertension, either alone or Treatment of hypertension, either alone or with other agentswith other agents Usually used after other agents have failedUsually used after other agents have failed

    due to side effectsdue to side effects Also may be used for treatment of severe Also may be used for treatment of severe

    dysmenorrhea, menopausal flushing, glaucomadysmenorrhea, menopausal flushing, glaucoma Clonidine is useful in the management of Clonidine is useful in the management of

    withdrawal symptoms in opioidwithdrawal symptoms in opioid- - or nicotineor nicotine- -dependent personsdependent persons

  • 8/8/2019 Antihypertensives_upd

    25/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Adrenergic Agents Adrenergic AgentsTherapeutic UsesTherapeutic Uses

    Adrenergic neuronal blockers Adrenergic neuronal blockers(peripherally acting)(peripherally acting)

    Treatment of hypertension, either alone or withTreatment of hypertension, either alone or withother agentsother agents

    Seldom used because of frequent side effectsSeldom used because of frequent side effects

  • 8/8/2019 Antihypertensives_upd

    26/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Adrenergic Agents Adrenergic AgentsSide EffectsSide Effects

    Most common:Most common: dry mouthdry mouth drowsinessdrowsinesssedationsedation constipationconstipation

    Other:Other: headachesheadaches sleep disturbancessleep disturbancesnauseanausea rashrashcardiac disturbances (palpitations)cardiac disturbances (palpitations)

    HIGH INCIDENCE OF ORTHOSTATIC HYPOTENSIONHIGH INCIDENCE OF ORTHOSTATIC HYPOTENSION

  • 8/8/2019 Antihypertensives_upd

    27/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    CategoriesCategories Angiotensin Angiotensin- -Converting Enzyme InhibitorsConverting Enzyme Inhibitors

    (ACE Inhibitors)(ACE Inhibitors)

    Large group of safe and effective drugsLarge group of safe and effective drugs

    Often used as firstOften used as first- -line agents for CHFline agents for CHFand hypertensionand hypertension

    May be combined with a thiazide diureticMay be combined with a thiazide diureticor calcium channel blocker or calcium channel blocker

  • 8/8/2019 Antihypertensives_upd

    28/56

  • 8/8/2019 Antihypertensives_upd

    29/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Mechanism of ActionMechanism of Action ACE Inhibitors ACE Inhibitors

    Aldosterone stimulates water and sodium resorption. Aldosterone stimulates water and sodium resorption.

    Result: increased blood volume, increased preload,Result: increased blood volume, increased preload,and increased Band increased B

  • 8/8/2019 Antihypertensives_upd

    30/56

  • 8/8/2019 Antihypertensives_upd

    31/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents Antihypertensive Agents ACE Inhibitors ACE Inhibitors

    captopril (Capoten)captopril (Capoten)

    Short half Short half- -life, must be dosed more frequentlylife, must be dosed more frequentlythan othersthan othersenalapril (Vasotec)enalapril (Vasotec)

    The only ACE inhibitor available in oral andThe only ACE inhibitor available in oral andparenteral formsparenteral forms

    lisinopril (Prinivil and Zestril) and quinapril (Accupril)lisinopril (Prinivil and Zestril) and quinapril (Accupril)

    Newer agents, long half Newer agents, long half- -lives, oncelives, once- -aa--day dosingday dosing

    Several other agents availableSeveral other agents available

  • 8/8/2019 Antihypertensives_upd

    32/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Therapeutic UsesTherapeutic Uses ACE Inhibitors ACE Inhibitors

    HypertensionHypertension

    CHF (either alone or in combination with diureticsCHF (either alone or in combination with diureticsor other agents)or other agents)

    Slows progression of left ventricular hypertrophySlows progression of left ventricular hypertrophy

    after an MIafter an MIRenal protective effects in patients with diabetesRenal protective effects in patients with diabetes

    Drugs of choice in hypertensive patients with CHFDrugs of choice in hypertensive patients with CHF

  • 8/8/2019 Antihypertensives_upd

    33/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Side EffectsSide Effects ACE Inhibitors ACE Inhibitors

    FatigueFatigue DizzinessDizziness

    HeadacheHeadache Mood changesMood changesImpaired tasteImpaired taste

    Dry, nonproductive cough, reverses when therapy is stoppedDry, nonproductive cough, reverses when therapy is stopped

    NOTE: firstNOTE: first- -dose hypotensive effect may occur!!dose hypotensive effect may occur!!

  • 8/8/2019 Antihypertensives_upd

    34/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    CategoriesCategories Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers

    (A II Blockers or ARBs)(A II Blockers or ARBs)

    Newer classNewer class

    WellWell--toleratedtolerated

    Do not cause coughingDo not cause coughing

  • 8/8/2019 Antihypertensives_upd

    35/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Mechanism of ActionMechanism of Action Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers

    Allow angiotensin I to be converted to angiotensin II, Allow angiotensin I to be converted to angiotensin II,but block the receptors that receive angiotensin IIbut block the receptors that receive angiotensin II

    Block vasoconstriction and release of aldosteroneBlock vasoconstriction and release of aldosterone

  • 8/8/2019 Antihypertensives_upd

    36/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers

    losartan (Cozaar)losartan (Cozaar)

    eposartan (Teveten)eposartan (Teveten)

    valsartan (Diovan)valsartan (Diovan)

    irbesartan (Avapro)irbesartan (Avapro)

    candesartan (Atacand)candesartan (Atacand)

    telmisartan (Micardis)telmisartan (Micardis)

  • 8/8/2019 Antihypertensives_upd

    37/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Therapeutic UsesTherapeutic Uses Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers

    HypertensionHypertension

    Adjunctive agents for the treatment of CHF Adjunctive agents for the treatment of CHF

    May be used alone or with other agents suchMay be used alone or with other agents suchas diureticsas diuretics

  • 8/8/2019 Antihypertensives_upd

    38/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Side EffectsSide Effects Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers

    Upper respiratory infectionsUpper respiratory infections

    HeadacheHeadache

    May cause occasional dizziness, inability to sleep,May cause occasional dizziness, inability to sleep,diarrhea, dyspnea, heartburn, nasal congestion,diarrhea, dyspnea, heartburn, nasal congestion,back pain, fatigueback pain, fatigue

  • 8/8/2019 Antihypertensives_upd

    39/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    CategoriesCategoriesCalcium Channel BlockersCalcium Channel Blockers

    BenzothiazepinesBenzothiazepines

    DihydropyridinesDihydropyridines

    PhenylalkylaminesPhenylalkylamines

  • 8/8/2019 Antihypertensives_upd

    40/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Mechanism of ActionMechanism of ActionCalcium Channel BlockersCalcium Channel Blockers

    Cause smooth muscle relaxation by blocking theCause smooth muscle relaxation by blocking thebinding of calcium to its receptors, preventingbinding of calcium to its receptors, preventingmuscle contractionmuscle contraction

    This causes decreased peripheral smooth muscleThis causes decreased peripheral smooth muscletone, decreased systemic vascular resistancetone, decreased systemic vascular resistance

    Result: decreased blood pressureResult: decreased blood pressure

  • 8/8/2019 Antihypertensives_upd

    41/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents Antihypertensive Agents

    Calcium Channel BlockersCalcium Channel Blockers

    Benzothiazepines:Benzothiazepines:

    diltiazem (Cardizem, Dilacor)diltiazem (Cardizem, Dilacor)

    Phenylalkamines:Phenylalkamines:

    verapamil (Calan, Isoptin)verapamil (Calan, Isoptin)

    Dihydropyridines:Dihydropyridines: amlodipine (Norvasc), bepridil (Vascor),amlodipine (Norvasc), bepridil (Vascor),

    nicardipine (Cardene)nicardipine (Cardene)

    nifedipine (Procardia), nimodipine (Nimotop)nifedipine (Procardia), nimodipine (Nimotop)

  • 8/8/2019 Antihypertensives_upd

    42/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Therapeutic UsesTherapeutic UsesCalcium Channel BlockersCalcium Channel Blockers

    Angina Angina

    HypertensionHypertension

    DysrhythmiasDysrhythmias

    Migraine headachesMigraine headaches

  • 8/8/2019 Antihypertensives_upd

    43/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Side EffectsSide EffectsCalcium Channel BlockersCalcium Channel Blockers

    Cardiovascular Cardiovascular

    hypotension, palpitations, tachycardiahypotension, palpitations, tachycardia

    GastrointestinalGastrointestinal

    constipation, nauseaconstipation, nausea

    Other Other

    rash, flushing, peripheral edema, dermatitisrash, flushing, peripheral edema, dermatitis

  • 8/8/2019 Antihypertensives_upd

    44/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Diuretics Antihypertensive Agents: Diuretics

    Decrease the plasma and extracellular fluid volumesDecrease the plasma and extracellular fluid volumes

    Results:Results: decreased preloaddecreased preload

    decreased cardiac outputdecreased cardiac outputdecreased total peripheral resistancedecreased total peripheral resistance

    Overall effect:Overall effect: decreased workload of the heart,decreased workload of the heart,and decreased blood pressureand decreased blood pressure

  • 8/8/2019 Antihypertensives_upd

    45/56

  • 8/8/2019 Antihypertensives_upd

    46/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents Antihypertensive Agents

    VasodilatorsVasodilators

    diazoxide (Hyperstat)diazoxide (Hyperstat)

    hydralazine HCl (Apresoline)hydralazine HCl (Apresoline)

    minoxidil (Loniten, Rogaine)minoxidil (Loniten, Rogaine)

    sodium nitroprusside (Nipride, Nitropress)sodium nitroprusside (Nipride, Nitropress)

  • 8/8/2019 Antihypertensives_upd

    47/56

  • 8/8/2019 Antihypertensives_upd

    48/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Side Antihypertensive Agents: Side

    EffectsEffectsVasodilatorsVasodilators

    Hydralazine:Hydralazine:

    dizziness, headache, anxiety, tachycardia,dizziness, headache, anxiety, tachycardia,nausea and vomiting, diarrhea, anemia,nausea and vomiting, diarrhea, anemia,dyspnea, edema, nasal congestiondyspnea, edema, nasal congestion

    Sodium nitroprusside:Sodium nitroprusside:

    bradycardia, hypotension, possiblebradycardia, hypotension, possiblecyanide toxicitycyanide toxicity

  • 8/8/2019 Antihypertensives_upd

    49/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsBefore beginning therapy, obtain a thoroughBefore beginning therapy, obtain a thoroughhealth history and headhealth history and head- -toto--toe physicaltoe physicalexamination.examination.

    Assess for contraindications to specific Assess for contraindications to specificantihypertensive agents.antihypertensive agents.

    Assess for conditions that require cautious Assess for conditions that require cautioususe of these agents.use of these agents.

  • 8/8/2019 Antihypertensives_upd

    50/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsEducate patients about the importance of notEducate patients about the importance of notmissing a dose and taking the medications exactlymissing a dose and taking the medications exactlyas prescribed.as prescribed.

    Patients should never double up on doses if a dosePatients should never double up on doses if a doseis missed; check with physician for instructions onis missed; check with physician for instructions onwhat to do if a dose is missed.what to do if a dose is missed.

    Monitor BP during therapy. Instruct patients toMonitor BP during therapy. Instruct patients tokeep a journal of regular BP checks.keep a journal of regular BP checks.

  • 8/8/2019 Antihypertensives_upd

    51/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsInstruct patients that these drugs should not beInstruct patients that these drugs should not bestopped abruptly, as this may cause a reboundstopped abruptly, as this may cause a reboundhypertensive crisis, and perhaps lead to CVA.hypertensive crisis, and perhaps lead to CVA.

    Oral forms should be given with meals so thatOral forms should be given with meals so thatabsorption is more gradual and effective.absorption is more gradual and effective.

    Administer IV forms with extreme caution and Administer IV forms with extreme caution anduse an IV pump.use an IV pump.

  • 8/8/2019 Antihypertensives_upd

    52/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsRemind patients that medications is only part of Remind patients that medications is only part of therapy. Encourage patients to watch their diet,therapy. Encourage patients to watch their diet,stress level, weight, and alcohol intake.stress level, weight, and alcohol intake.

    Patients should avoid smoking and eating foodsPatients should avoid smoking and eating foodshigh in sodium.high in sodium.

    Encourage supervised exercise.Encourage supervised exercise.

  • 8/8/2019 Antihypertensives_upd

    53/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsInstruct patients to change positions slowly to avoidInstruct patients to change positions slowly to avoidsyncope from postural hypotension.syncope from postural hypotension.

    Patients should report unusual shortness of breath;Patients should report unusual shortness of breath;difficulty breathing; swelling of the feet, ankles, face,difficulty breathing; swelling of the feet, ankles, face,or around the eyes; weight gain or loss; chest pain;or around the eyes; weight gain or loss; chest pain;palpitations; or excessive fatigue.palpitations; or excessive fatigue.

  • 8/8/2019 Antihypertensives_upd

    54/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsMen taking these agents may not be aware thatMen taking these agents may not be aware thatimpotence is an expected effect. This may influenceimpotence is an expected effect. This may influencecompliance with drug therapy.compliance with drug therapy.

    If patients are experiencing serious side effects,If patients are experiencing serious side effects,or believe that the dose or medication needs toor believe that the dose or medication needs tobe changed, they should contact their physicianbe changed, they should contact their physicianimmediately.immediately.

  • 8/8/2019 Antihypertensives_upd

    55/56

    Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsHot tubs, showers, or baths; hot weather; prolongedHot tubs, showers, or baths; hot weather; prolongedsitting or standing; physical exercise; and alcoholsitting or standing; physical exercise; and alcoholingestion may aggravate low blood pressure,ingestion may aggravate low blood pressure,

    leading to fainting and injury. Patients shouldleading to fainting and injury. Patients shouldsit or lie down until symptoms subside.sit or lie down until symptoms subside.

    Patients should not take any other medications,Patients should not take any other medications,including OTC drugs, without first getting theincluding OTC drugs, without first getting theapproval of their physician.approval of their physician.

  • 8/8/2019 Antihypertensives_upd

    56/56

    C i h 2002 1998 El i S i (USA) All i h d

    Antihypertensive Agents: Antihypertensive Agents:

    Nursing ImplicationsNursing ImplicationsMonitor for side/adverse effectsMonitor for side/adverse effects(dizziness, orthostatic hypotension, fatigue)(dizziness, orthostatic hypotension, fatigue)and for toxic effects.and for toxic effects.

    Monitor for therapeutic effectsMonitor for therapeutic effects

    Blood pressure should be maintained at lessBlood pressure should be maintained at lessthan 140/90 mm Hgthan 140/90 mm Hg